Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Animal models of human type 1 diabetes.

Literature DB >> 19148193

Animal models of human type 1 diabetes.

Abstract

Type 1 diabetes is an immune-mediated disease in which pancreatic insulin-producing beta cells are damaged and destroyed. Animal models have served a prominent function in the development of the present ideas of pathogenesis and approaches to therapy. This commentary addresses the utility and limitations of these models for facilitating the 'translation' of immunology research into clinical applications.

Entities: Disease Species

Mesh：

Year: 2009 PMID： 19148193 DOI： 10.1038/ni0209-129

Source DB: PubMed Journal: Nat Immunol ISSN： 1529-2908 Impact factor: 25.606

23 in total

1. Ontogeny of T cell tolerance to peripherally expressed antigens.

Authors: D J Morgan; C Kurts; H T Kreuwel; K L Holst; W R Heath; L A Sherman
Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205

Review 2. A comprehensive review of interventions in the NOD mouse and implications for translation.

Authors: Lisl K M Shoda; Daniel L Young; Saroja Ramanujan; Chan C Whiting; Mark A Atkinson; Jeffrey A Bluestone; George S Eisenbarth; Diane Mathis; Aldo A Rossini; Scott E Campbell; Richard Kahn; Huub T C Kreuwel
Journal: Immunity Date: 2005-08 Impact factor: 31.745

Review 3. Epidemiology of type 1 Diabetes Mellitus.

Authors: Marian Rewers; Jill Norris; Dana Dabelea
Journal: Adv Exp Med Biol Date: 2004 Impact factor: 2.622

4. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.

Authors: David V Serreze; Michele P Marron; Teresa P Dilorenzo
Journal: Ann N Y Acad Sci Date: 2007-03-21 Impact factor: 5.691

5. A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8.

Authors: Jacqueline A Taylor; Evis Havari; Marcia F McInerney; Roderick Bronson; Kai W Wucherpfennig; Myra A Lipes
Journal: J Immunol Date: 2004-02-15 Impact factor: 5.422

6. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors: Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal: Proc Natl Acad Sci U S A Date: 2007-03-14 Impact factor: 11.205

7. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Authors: Júlio C Voltarelli; Carlos E B Couri; Ana B P L Stracieri; Maria C Oliveira; Daniela A Moraes; Fabiano Pieroni; Marina Coutinho; Kelen C R Malmegrim; Maria C Foss-Freitas; Belinda P Simões; Milton C Foss; Elizabeth Squiers; Richard K Burt
Journal: JAMA Date: 2007-04-11 Impact factor: 56.272

8. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.

Authors: M G von Herrath; J Dockter; M B Oldstone
Journal: Immunity Date: 1994-06 Impact factor: 31.745

9. Regulated beta-cell regeneration in the adult mouse pancreas.

Authors: David A Cano; Ingrid C Rulifson; Patrick W Heiser; Lamorna B Swigart; Stella Pelengaris; Mike German; Gerard I Evan; Jeffrey A Bluestone; Matthias Hebrok
Journal: Diabetes Date: 2007-12-14 Impact factor: 9.461

10. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity.

Authors: C Kurts; F R Carbone; M Barnden; E Blanas; J Allison; W R Heath; J F Miller
Journal: J Exp Med Date: 1997-12-15 Impact factor: 14.307

36 in total

Review 1. Gender differences in autoimmunity associated with exposure to environmental factors.

Authors: K Michael Pollard
Journal: J Autoimmun Date: 2011-12-03 Impact factor: 7.094

Review 2. Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors: Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal: Pharm Res Date: 2011-11-09 Impact factor: 4.200

Review 3. Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors: Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal: Endocrinol Metab Clin North Am Date: 2010-07-08 Impact factor: 4.741

Review 4. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

Authors: Suchitra Prasad; Dan Xu; Stephen D Miller
Journal: Rev Diabet Stud Date: 2012-12-28

Review 5. Using stem cells to study and possibly treat type 1 diabetes.

Authors: D A Melton
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2011-08-12 Impact factor: 6.237

Review 6. Implant healing in experimental animal models of diabetes.

Authors: Nga N Le; Michael B Rose; Howard Levinson; Bruce Klitzman
Journal: J Diabetes Sci Technol Date: 2011-05-01

Review 7. Stem cell educator therapy and induction of immune balance.

Authors: Yong Zhao
Journal: Curr Diab Rep Date: 2012-10 Impact factor: 4.810

8. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.

Authors: C M Kiekhaefer; B Weber; M Huggins; C Gorichanaz; J A Nehring; H F DeLuca
Journal: Clin Exp Immunol Date: 2011-12 Impact factor: 4.330

9. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors: Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal: Diabetes Date: 2010-05-18 Impact factor: 9.461

Review 10. Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop.

Authors: Dori Germolec; Dwight H Kono; Jean C Pfau; K Michael Pollard
Journal: J Autoimmun Date: 2012-06-27 Impact factor: 7.094